Fairfield, Connecticut headquartered General Electric Co.'s shares saw a drop of 1.35% from its previous closing price and finished Wednesday's trading session at $28.49. A total volume of 30.81 million shares was traded, which was above their three months average volume of 30.30 million shares. The stock is trading below its 50-day moving average by 4.15%. Moreover, shares of General Electric, which operates as an infrastructure and financial services company worldwide, have a Relative Strength Index (RSI) of 36.39.
On October 14th, 2016, research firm UBS reiterated its 'Buy' rating on the Company's stock with a decrease of the target price from $37 a share to $34 a share.
On November 02nd, 2016, GE Healthcare's Life Sciences business and Valneva SE shared the results of a successful collaboration to optimize virus productivity in Valneva's EB66® cell-line, a proprietary technology for the production of a wide variety of vaccines, including human and animal health vaccines. The collaboration has resulted in the creation of a commercial cell culture medium, HyClone™ CDM4Avian, developed specifically to address the challenges of media variability. The new medium supports efficient and predictable virus production for manufacturers utilizing EB66® cells, helping to increase production reliability and improve end-product quality. Sign up and read the free research report on GE at:
On Wednesday, shares in New Jersey-based Honeywell International Inc. recorded a trading volume of 4.63 million shares, which was above their three months average volume of 3.24 million shares. The stock ended the session 0.63% lower at $108.46. The Company's shares have gained 6.41% on an YTD basis and are trading 2.73% below their 200-day moving average. Furthermore, shares of Honeywell International, which operates as a diversified technology and manufacturing company worldwide, have an RSI of 40.44.
On October 10th, 2016, research firm RBC Capital Markets reiterated its 'Outperform' rating on the Company's stock with a decrease of the target price from $138 a share to $133 a share.
On November 02nd, 2016, Honeywell announced a $15 million smart grid project with Connexus Energy, Minnesota's largest customer-owned electric cooperative, to deploy advanced smart grid technology to improve electricity service and reliability. Under the project, Honeywell will install more than 138,000 of its EnergyAxis® connected meters and its new SynergyNet™ mesh networking platform for the utility. The complimentary research report on HON can be downloaded at:
Shares in Washington, the District of Columbia headquartered Danaher Corp. closed the day at $76.74, slightly down 0.38% from the last trading session. The stock recorded a trading volume of 2.77 million shares. The Company's shares have gained 9.52% since the start of this year, and are trading 3.15% above their 200-day moving average. Additionally, shares of Danaher, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide, have an RSI of 42.61.
On October 20th, 2016, Danaher reported Q3 2016 net earnings of $402.6 million, or $0.57 per diluted share, which represents a 6% y-o-y increase. For Q3 2016, revenues increased 17.5% y-o-y to $4.1 billion, with core revenue growth of 3.0%. Year-to-date operating cash flow of $2.4 billion was up 29% on the comparable 2015 amount. Register for free on Stock-Callers.com and access the latest report on DHR at:
At the closing bell yesterday, shares in Dublin, Ireland-based Eaton Corp. PLC ended 0.30% higher at $60.88. A total volume of 4.16 million shares was traded, which was above their three months average volume of 2.46 million shares. The stock has advanced 20.29% on an YTD basis. The Company's shares are trading above their 200-day moving average by 0.06%. Furthermore, shares of Eaton, which operates as a power management company worldwide, have an RSI of 37.25.
On November 01st, 2016, Eaton reported Q3 2016 net income of $1.15 per share, up 20% compared to Q3 2015 net income per share of $0.96. Sales in Q3 2016 were $5.0 billion, down 4% from Q3 2015 sales of $5.20 billion. The sales decline consisted of 3% decline in organic sales and 1% from negative currency translation. The company's operating cash flow in Q3 2016 was $798 million.
Yesterday, research firm RBC Capital Markets reiterated its 'Sector Perform' rating on the Company's stock with a decrease of the target price from $68 a share to $65 a share. Get free access to your research report on ETN at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA